Get help now — free helplines

You can call any of these for free. You do not need a diagnosis, an appointment, or a crisis to call — questions and plain exhaustion are reasons enough.

  • Alzheimer's Association 24/7 Helpline 800-272-3900 24 hours a day, 365 days a year Free, confidential support and information for people with dementia, caregivers, families and the public. Master's-level clinicians. Also Spanish.
  • 988 Suicide & Crisis Lifeline 988 24/7 Call or text 988, or chat at 988lifeline.org. For anyone in emotional distress or a mental-health crisis, including caregivers.
  • Alzheimer's Foundation of America (AFA) Helpline 866-232-8484 9:00 am - 9:00 pm ET, seven days a week Licensed social workers providing support, info and referrals. Also text message and web chat. Text: 646-586-5283

In a medical emergency, call 911. More numbers, and what each line does, on the help page.

This page is alzhub.org's plain-English summary of a published study, not the paper itself. It is generated from the record we hold for this study, sourced and linked below — check the original for the full text and methods.

✓ Peer-reviewed alzhub usefulness score 67 out of 100. Risk genes beyond APOE

Topic: Amyloid, tau and blood-test diagnosis

Researchers performed a genome-wide association study of clinically diagnosed Alzheimer's disease and disease-by-proxy. The meta-analysis identified new risk loci and potential causative genes that are strongly expressed in immune-related tissues and cell types. Furthermore, the findings indicated biological mechanisms involving lipid-related processes and suggested a protective effect of cognitive ability on disease risk.

Key findings

Why it matters

A genome-wide meta-analysis reporting new loci and functional pathways that influence Alzheimer's disease risk. Loci and pathways indicate where treatments might be sought; this work does not supply one.

Study details

How this study scored 67/100
How this study's score is builtJournal tier 9 of 10; Journal's citation record 4 of 4; Study design 0 of 12; Strength of evidence 1 of 5; Peer-review validation 10 of 10; How recent 2 of 5; Sample size 0 of 4; Effect reported 0 of 3; Studied in people 0 of 3; Randomised / blinded 0 of 2; Times cited 7 of 7; Citations per year 5 of 5; Impact for its field and year 6 of 6; Cited by studies here 5 of 6; Still being cited 4 of 4; Senior author's track record 4 of 4; Institution's track record 3 of 3; Multi-centre collaboration 3 of 3; Indexed in PubMed 2 of 2; Free to read 2 of 2. Total 67 of 100.67 of 100 points earned33 not earned

Published in a leading specialty journal. Scored zero for study design, sample size, effect reported, studied in people and randomised / blinded because the record does not state it.

ComponentPointsWhy
Journal tier 9 / 10 Tier 2 — leading specialty journal (Nature Genetics)
Journal's citation record 4 / 4 Nature Genetics: journal h-index 776 (OpenAlex, 2026-10-29)
Study design 0 / 12 No study design recorded — scores zero, not guessed (not stated in the record — scored 0)
Strength of evidence 1 / 5 Rated “low” in our summary
Peer-review validation 10 / 10 Peer-reviewed. Published as an article in a named peer-reviewed journal.
How recent 2 / 5 2019 — within 10 year(s) of the newest study here
Sample size 0 / 4 Participant count not stated — scores zero (not stated in the record — scored 0)
Effect reported 0 / 3 No effect size reported — scores zero (not stated in the record — scored 0)
Studied in people 0 / 3 Not stated whether this was studied in people — scores zero (not stated in the record — scored 0)
Randomised / blinded 0 / 2 No randomisation or blinding stated — scores zero (not stated in the record — scored 0)
Times cited 7 / 7 Cited 2,285 times (OpenAlex, 2026-10-10)
Citations per year 5 / 5 253.9 citations a year over 9 year(s) since 2019
Impact for its field and year 6 / 6 Cited 168.3× the average for papers of its field and year (OpenAlex FWCI)
Cited by studies here 5 / 6 Cited by 106 other studies in this library
Still being cited 4 / 4 Cited 796 times in 2024–2026 (2026 still in progress; OpenAlex)
Senior author's track record 4 / 4 Last-listed author Daniëlle Posthuma: h-index 128 (OpenAlex, whole career)
Institution's track record 3 / 3 Broad Institute: institution h-index 2,541 (OpenAlex)
Multi-centre collaboration 3 / 3 OpenAlex lists 39 institution(s) in 7 countries
Indexed in PubMed 2 / 2 Indexed in PubMed (PMID 30617256)
Free to read 2 / 2 Free to read
Total 67 / 100 —

What each of these 20 components measures, and what this score is not →

Read the original

Full text: free to read — OpenAlex lists this copy as free to read: the link above (checked 6 Feb 1020).

Cite this study APA, Vancouver, BibTeX · download .bib or .ris

Built from the record alzhub holds for this paper, not looked up. Volume, issue and page numbers are not held in the record. The record's author list ends in “et al.”, so not every author is named. Check the citation against the original before you use it.

APA 7th

Jansen, I. E., Savage, J. E., Watanabe, K., Bryois, J., Williams, D. M., Steinberg, S., et al. (2019). Genome-wide meta-analysis identifies new loci and functional pathways influencing Alzheimer’s disease risk. Nature Genetics. https://doi.org/10.1038/s41588-018-0311-9

Vancouver

Jansen IE, Savage JE, Watanabe K, Bryois J, Williams DM, Steinberg S, et al. Genome-wide meta-analysis identifies new loci and functional pathways influencing Alzheimer’s disease risk. Nature Genetics. 2019. doi:10.1038/s41588-018-0311-9. PMID: 30617256.

BibTeX

@article{jansen2019-30617256,
  author  = {Jansen, Iris E. and Savage, Jeanne E. and Watanabe, Kyoko and Bryois, Julien and Williams, Dylan M. and Steinberg, Stacy and Sealock, Julia and Karlsson, Ida and others},
  title   = {{Genome-wide meta-analysis identifies new loci and functional pathways influencing Alzheimer’s disease risk}},
  journal = {Nature Genetics},
  year    = {2019},
  doi     = {10.1038/s41588-018-0311-9},
  pmid    = {30617256},
  url     = {https://doi.org/10.1038/s41588-018-0311-9}
}

Studies this one cites

Referenced by this study and also in the alzhub library, so you can read them here. Showing 12 of 14.

Later studies that cite this one

106 studies in the alzhub library list this one in their references. Showing the 8 highest-scoring.

Related studies in Risk genes beyond APOE

Also tagged “amyloid-beta”

1,339 studies in the library carry the topic tag “amyloid-beta”; these are this study's neighbours in a fixed, alphabetical-by-hash tour of them, not the closest in content. All 1,339 tagged studies.

Similar studies

More on Risk genes beyond APOE

See all studies in Risk genes beyond APOE →